

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.44426445 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.23232909 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.18687709 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.18687709 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.98306296 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.98306296 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.98306296 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 3.98306296 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 3.98306296 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 3.98306296 |
| 11 | daunorubicin metabolic process (GO:0044597) | 3.98048572 |
| 12 | polyketide metabolic process (GO:0030638) | 3.98048572 |
| 13 | doxorubicin metabolic process (GO:0044598) | 3.98048572 |
| 14 | regulation of gamma-delta T cell activation (GO:0046643) | 3.77621427 |
| 15 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.55651928 |
| 16 | detection of molecule of bacterial origin (GO:0032490) | 3.54915378 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.45210746 |
| 18 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.44860640 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.40997226 |
| 20 | response to peptidoglycan (GO:0032494) | 3.40419931 |
| 21 | positive regulation of interferon-alpha production (GO:0032727) | 3.36728408 |
| 22 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.36725903 |
| 23 | positive regulation of B cell differentiation (GO:0045579) | 3.36032936 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.31933270 |
| 25 | response to type I interferon (GO:0034340) | 3.30293441 |
| 26 | detection of other organism (GO:0098543) | 3.29561072 |
| 27 | cellular response to type I interferon (GO:0071357) | 3.27210484 |
| 28 | type I interferon signaling pathway (GO:0060337) | 3.27210484 |
| 29 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.23861016 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.23861016 |
| 31 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.23518202 |
| 32 | interferon-gamma production (GO:0032609) | 3.23107441 |
| 33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.22521607 |
| 34 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.22085145 |
| 35 | NIK/NF-kappaB signaling (GO:0038061) | 3.16643535 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.16087231 |
| 37 | response to muramyl dipeptide (GO:0032495) | 3.15184255 |
| 38 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.10685351 |
| 39 | cellular extravasation (GO:0045123) | 3.09659265 |
| 40 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.09511875 |
| 41 | regulation of B cell differentiation (GO:0045577) | 3.05575189 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04606988 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.01849980 |
| 44 | response to interferon-alpha (GO:0035455) | 3.01759889 |
| 45 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.00508761 |
| 46 | microglial cell activation (GO:0001774) | 2.96653529 |
| 47 | detection of external biotic stimulus (GO:0098581) | 2.96225686 |
| 48 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94667973 |
| 49 | positive regulation of type 2 immune response (GO:0002830) | 2.92667288 |
| 50 | negative regulation of viral genome replication (GO:0045071) | 2.92458575 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91272340 |
| 52 | response to host immune response (GO:0052572) | 2.89741271 |
| 53 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.89741271 |
| 54 | detection of bacterium (GO:0016045) | 2.89280028 |
| 55 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.88385446 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 2.86481718 |
| 57 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.86036738 |
| 58 | positive regulation of interferon-beta production (GO:0032728) | 2.85485993 |
| 59 | leukocyte aggregation (GO:0070486) | 2.85325703 |
| 60 | myeloid dendritic cell activation (GO:0001773) | 2.84838339 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84547698 |
| 62 | T-helper 1 type immune response (GO:0042088) | 2.83901773 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 2.82668609 |
| 64 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.80297640 |
| 65 | definitive hemopoiesis (GO:0060216) | 2.77980288 |
| 66 | macrophage activation (GO:0042116) | 2.77898014 |
| 67 | detection of biotic stimulus (GO:0009595) | 2.77133197 |
| 68 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.76894406 |
| 69 | defense response to protozoan (GO:0042832) | 2.71882896 |
| 70 | mature B cell differentiation (GO:0002335) | 2.71544771 |
| 71 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71067945 |
| 72 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70005529 |
| 73 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69724215 |
| 74 | mature B cell differentiation involved in immune response (GO:0002313) | 2.69489091 |
| 75 | response to interferon-beta (GO:0035456) | 2.69023084 |
| 76 | energy homeostasis (GO:0097009) | 2.68736199 |
| 77 | regulation of podosome assembly (GO:0071801) | 2.68625109 |
| 78 | negative regulation of mast cell activation (GO:0033004) | 2.66596369 |
| 79 | regulation of tolerance induction (GO:0002643) | 2.66371091 |
| 80 | regulation of mast cell activation (GO:0033003) | 2.65794526 |
| 81 | regulation of type 2 immune response (GO:0002828) | 2.64987387 |
| 82 | negative regulation of interleukin-12 production (GO:0032695) | 2.64123643 |
| 83 | neutrophil activation (GO:0042119) | 2.61943403 |
| 84 | B cell mediated immunity (GO:0019724) | 2.61939777 |
| 85 | regulation of leukocyte degranulation (GO:0043300) | 2.61795693 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.61716809 |
| 87 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.60637476 |
| 88 | regulation of mononuclear cell migration (GO:0071675) | 2.60230231 |
| 89 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60027606 |
| 90 | response to host (GO:0075136) | 2.60027606 |
| 91 | response to host defenses (GO:0052200) | 2.60027606 |
| 92 | superoxide anion generation (GO:0042554) | 2.58467929 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.58037878 |
| 94 | T cell migration (GO:0072678) | 2.57238252 |
| 95 | pinocytosis (GO:0006907) | 2.57231577 |
| 96 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.57114912 |
| 97 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.56403984 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.56386676 |
| 99 | positive regulation of mast cell activation (GO:0033005) | 2.55995507 |
| 100 | negative regulation of T cell mediated immunity (GO:0002710) | 2.55656958 |
| 101 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.55415892 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 2.54265609 |
| 103 | germinal center formation (GO:0002467) | 2.54179854 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.53760385 |
| 105 | negative regulation of innate immune response (GO:0045824) | 2.53408605 |
| 106 | phagocytosis, engulfment (GO:0006911) | 2.53037118 |
| 107 | response to protozoan (GO:0001562) | 2.52491092 |
| 108 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51806726 |
| 109 | cellular response to interferon-gamma (GO:0071346) | 2.51201192 |
| 110 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.50417137 |
| 111 | regulation of interleukin-12 production (GO:0032655) | 2.48613339 |
| 112 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.48560179 |
| 113 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.48018356 |
| 114 | regulation of antigen processing and presentation (GO:0002577) | 2.47828661 |
| 115 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.47827005 |
| 116 | regulation of vitamin metabolic process (GO:0030656) | 2.47690422 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 2.47306210 |
| 118 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.46542207 |
| 119 | positive regulation of humoral immune response (GO:0002922) | 2.46347688 |
| 120 | lymphocyte chemotaxis (GO:0048247) | 2.45900133 |
| 121 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.45812275 |
| 122 | cellular response to exogenous dsRNA (GO:0071360) | 2.44879393 |
| 123 | negative regulation of granulocyte differentiation (GO:0030853) | 2.44732194 |
| 124 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.44330947 |
| 125 | neutrophil mediated immunity (GO:0002446) | 2.43078536 |
| 126 | regulation of mast cell degranulation (GO:0043304) | 2.42603382 |
| 127 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.41334904 |
| 128 | valine metabolic process (GO:0006573) | 2.40369384 |
| 129 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.38464296 |
| 130 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38208360 |
| 131 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.37908555 |
| 132 | myeloid cell activation involved in immune response (GO:0002275) | 2.37666679 |
| 133 | granulocyte activation (GO:0036230) | 2.35422960 |
| 134 | I-kappaB kinase/NF-kappaB signaling (GO:0007249) | 2.35307875 |
| 135 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.35302023 |
| 136 | myeloid leukocyte activation (GO:0002274) | 2.34766859 |
| 137 | I-kappaB phosphorylation (GO:0007252) | 2.32294801 |
| 138 | dendritic cell migration (GO:0036336) | 2.31352550 |
| 139 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.30282059 |
| 140 | megakaryocyte development (GO:0035855) | 2.28476340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.94265179 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.36302732 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.27724355 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.13417890 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.90213379 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.84522513 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.75587933 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64759559 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.34217770 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.29447615 |
| 11 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.25932497 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.89724093 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71624246 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65104351 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.59904917 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.51735222 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48771906 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.48008547 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.39987440 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.29917620 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.27493458 |
| 22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26419150 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23753045 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21063455 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15782519 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.09002899 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.06061540 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05917902 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00353756 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96133414 |
| 31 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.95408261 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94220009 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.94023685 |
| 34 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88277651 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87226789 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.84507374 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81145916 |
| 38 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.79197490 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73614822 |
| 40 | MYB_26560356_Chip-Seq_TH2_Human | 1.73091010 |
| 41 | GATA1_19941826_ChIP-Seq_K562_Human | 1.72802058 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.72549662 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69710880 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.67865907 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.63799419 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63355441 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.59617170 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.57529691 |
| 49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.56727136 |
| 50 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.56633851 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.55805818 |
| 52 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52320594 |
| 53 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51787024 |
| 54 | MYC_22102868_ChIP-Seq_BL_Human | 1.50428705 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49889852 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49244226 |
| 57 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.47585315 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46518146 |
| 59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45942378 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44824762 |
| 61 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.39691903 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37675780 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37545116 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.36942312 |
| 65 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34978877 |
| 66 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34675480 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34218040 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.31397226 |
| 69 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31112327 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30907372 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29800955 |
| 72 | MAF_26560356_Chip-Seq_TH2_Human | 1.29668280 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28568981 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25710318 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23926263 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23241346 |
| 77 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23214852 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.21328657 |
| 79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19541783 |
| 80 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18176051 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16866142 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16715333 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.16190877 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15470159 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15266802 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14329850 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12107150 |
| 88 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10669842 |
| 89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10458929 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.10185806 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.09998874 |
| 92 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09185732 |
| 93 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08418671 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.05652133 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03188853 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02804365 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02364124 |
| 98 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00516084 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00357761 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.00259046 |
| 101 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00022504 |
| 102 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.99524382 |
| 103 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99051705 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98912940 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98902084 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97774002 |
| 107 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.97743641 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97095988 |
| 109 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97059278 |
| 110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95645176 |
| 111 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94845450 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94520939 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94349748 |
| 114 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92275015 |
| 115 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92206011 |
| 116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91642261 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91315149 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90672676 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88696062 |
| 120 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87790631 |
| 121 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87691896 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87392451 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85450785 |
| 124 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.84460897 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83031777 |
| 126 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.82403850 |
| 127 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.81154252 |
| 128 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.80729918 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80375824 |
| 130 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.79069884 |
| 131 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.78899487 |
| 132 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.77630099 |
| 133 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77446868 |
| 134 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.76100835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.49281600 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.47080957 |
| 3 | MP0003436_decreased_susceptibility_to | 2.73082188 |
| 4 | MP0004510_myositis | 2.65282473 |
| 5 | MP0009785_altered_susceptibility_to | 2.64664883 |
| 6 | MP0005671_abnormal_response_to | 2.64032440 |
| 7 | MP0002419_abnormal_innate_immunity | 2.44215639 |
| 8 | MP0001790_abnormal_immune_system | 2.41596569 |
| 9 | MP0005387_immune_system_phenotype | 2.41596569 |
| 10 | MP0003724_increased_susceptibility_to | 2.40888696 |
| 11 | MP0000685_abnormal_immune_system | 2.39669384 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.34226698 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.29106512 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.23974527 |
| 15 | MP0001800_abnormal_humoral_immune | 2.22801910 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.19707240 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.17418751 |
| 18 | MP0005025_abnormal_response_to | 2.15789270 |
| 19 | MP0002723_abnormal_immune_serum | 2.12416044 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.05319652 |
| 21 | MP0005451_abnormal_body_composition | 1.98970880 |
| 22 | MP0005174_abnormal_tail_pigmentation | 1.97206767 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.95108344 |
| 24 | MP0001819_abnormal_immune_cell | 1.94732500 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.88114960 |
| 26 | MP0006082_CNS_inflammation | 1.85533030 |
| 27 | MP0003075_altered_response_to | 1.84677313 |
| 28 | MP0005365_abnormal_bile_salt | 1.80581280 |
| 29 | MP0001853_heart_inflammation | 1.74845037 |
| 30 | MP0008004_abnormal_stomach_pH | 1.71600641 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.70513408 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.62712055 |
| 33 | MP0002405_respiratory_system_inflammati | 1.62540563 |
| 34 | MP0005075_abnormal_melanosome_morpholog | 1.62046254 |
| 35 | MP0009764_decreased_sensitivity_to | 1.58409030 |
| 36 | MP0002398_abnormal_bone_marrow | 1.57714920 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.57593013 |
| 38 | MP0009697_abnormal_copulation | 1.55770723 |
| 39 | MP0009840_abnormal_foam_cell | 1.54441453 |
| 40 | MP0000716_abnormal_immune_system | 1.54199556 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.53256122 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.52361277 |
| 43 | MP0008469_abnormal_protein_level | 1.51518673 |
| 44 | MP0008260_abnormal_autophagy | 1.47469283 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.46060946 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.44401073 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.42278802 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.42278802 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.40787386 |
| 50 | MP0000604_amyloidosis | 1.40431404 |
| 51 | MP0002132_abnormal_respiratory_system | 1.38958369 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.35187668 |
| 53 | MP0002332_abnormal_exercise_endurance | 1.34488114 |
| 54 | MP0001873_stomach_inflammation | 1.33830010 |
| 55 | MP0009278_abnormal_bone_marrow | 1.30633042 |
| 56 | MP0005670_abnormal_white_adipose | 1.29576984 |
| 57 | MP0006054_spinal_hemorrhage | 1.28817650 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.28506930 |
| 59 | MP0002095_abnormal_skin_pigmentation | 1.28031352 |
| 60 | MP0002429_abnormal_blood_cell | 1.27682812 |
| 61 | MP0005166_decreased_susceptibility_to | 1.27421150 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.27221135 |
| 63 | MP0002722_abnormal_immune_system | 1.26724081 |
| 64 | MP0003252_abnormal_bile_duct | 1.24826188 |
| 65 | MP0004947_skin_inflammation | 1.24808109 |
| 66 | MP0003806_abnormal_nucleotide_metabolis | 1.24443033 |
| 67 | MP0003448_altered_tumor_morphology | 1.24351810 |
| 68 | MP0000490_abnormal_crypts_of | 1.24233630 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.23905449 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.22127074 |
| 71 | MP0003172_abnormal_lysosome_physiology | 1.20763714 |
| 72 | MP0002933_joint_inflammation | 1.20687362 |
| 73 | MP0005360_urolithiasis | 1.20466289 |
| 74 | MP0000371_diluted_coat_color | 1.19887444 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 1.18927155 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.18776901 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.17299213 |
| 78 | MP0003183_abnormal_peptide_metabolism | 1.17069114 |
| 79 | MP0005167_abnormal_blood-brain_barrier | 1.16985772 |
| 80 | MP0005164_abnormal_response_to | 1.16196693 |
| 81 | MP0003690_abnormal_glial_cell | 1.15686683 |
| 82 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14560062 |
| 83 | MP0001851_eye_inflammation | 1.13605472 |
| 84 | MP0005310_abnormal_salivary_gland | 1.13146588 |
| 85 | MP0003300_gastrointestinal_ulcer | 1.12363955 |
| 86 | MP0003091_abnormal_cell_migration | 1.08928023 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 1.07895190 |
| 88 | MP0004381_abnormal_hair_follicle | 1.05023043 |
| 89 | MP0002006_tumorigenesis | 1.04185843 |
| 90 | MP0004264_abnormal_extraembryonic_tissu | 1.04128241 |
| 91 | MP0006292_abnormal_olfactory_placode | 1.03728584 |
| 92 | MP0001764_abnormal_homeostasis | 1.02932081 |
| 93 | MP0000858_altered_metastatic_potential | 1.02638089 |
| 94 | MP0009763_increased_sensitivity_to | 1.02568135 |
| 95 | MP0004883_abnormal_blood_vessel | 1.01954225 |
| 96 | MP0002139_abnormal_hepatobiliary_system | 1.01474924 |
| 97 | MP0001666_abnormal_nutrient_absorption | 0.98640196 |
| 98 | MP0004147_increased_porphyrin_level | 0.98370301 |
| 99 | MP0003828_pulmonary_edema | 0.94951167 |
| 100 | MP0005165_increased_susceptibility_to | 0.94825917 |
| 101 | MP0003186_abnormal_redox_activity | 0.94369396 |
| 102 | MP0002928_abnormal_bile_duct | 0.93587786 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.92283595 |
| 104 | MP0003943_abnormal_hepatobiliary_system | 0.91470035 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.91108448 |
| 106 | MP0000249_abnormal_blood_vessel | 0.90945881 |
| 107 | MP0000609_abnormal_liver_physiology | 0.90704939 |
| 108 | MP0002254_reproductive_system_inflammat | 0.90675616 |
| 109 | MP0003566_abnormal_cell_adhesion | 0.89041440 |
| 110 | MP0000343_altered_response_to | 0.88579958 |
| 111 | MP0003866_abnormal_defecation | 0.87805515 |
| 112 | MP0001663_abnormal_digestive_system | 0.86484563 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.85857557 |
| 114 | MP0003329_amyloid_beta_deposits | 0.84700560 |
| 115 | MP0005023_abnormal_wound_healing | 0.84413031 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.83103300 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.82534381 |
| 118 | MP0002877_abnormal_melanocyte_morpholog | 0.80812597 |
| 119 | MP0005390_skeleton_phenotype | 0.78787018 |
| 120 | MP0000569_abnormal_digit_pigmentation | 0.78773484 |
| 121 | MP0003795_abnormal_bone_structure | 0.77116069 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.77087785 |
| 123 | MP0008874_decreased_physiological_sensi | 0.76262420 |
| 124 | MP0001849_ear_inflammation | 0.74938299 |
| 125 | MP0004130_abnormal_muscle_cell | 0.73119644 |
| 126 | MP0010329_abnormal_lipoprotein_level | 0.72845960 |
| 127 | MP0001542_abnormal_bone_strength | 0.72824651 |
| 128 | MP0003279_aneurysm | 0.72519260 |
| 129 | MP0003045_fibrosis | 0.72455482 |
| 130 | MP0003868_abnormal_feces_composition | 0.71380946 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.70975873 |
| 132 | MP0001958_emphysema | 0.63763287 |
| 133 | MP0000920_abnormal_myelination | 0.60173614 |
| 134 | MP0005535_abnormal_body_temperature | 0.57682806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glycolipid metabolism (HP:0010969) | 4.62853122 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.62853122 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.62853122 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.05933243 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.87475903 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.70866682 |
| 7 | Myositis (HP:0100614) | 3.68606763 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.52066884 |
| 9 | Optic neuritis (HP:0100653) | 3.47360926 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.47360926 |
| 11 | Orchitis (HP:0100796) | 3.43159597 |
| 12 | Purpura (HP:0000979) | 3.24369028 |
| 13 | Reduced antithrombin III activity (HP:0001976) | 3.20399839 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.15223315 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.14422052 |
| 16 | Periodontitis (HP:0000704) | 3.09527125 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.06750241 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.05821189 |
| 19 | Loss of speech (HP:0002371) | 3.04989449 |
| 20 | Joint hemorrhage (HP:0005261) | 3.04654026 |
| 21 | Prolonged bleeding time (HP:0003010) | 3.00473134 |
| 22 | Chronic otitis media (HP:0000389) | 2.88505608 |
| 23 | Petechiae (HP:0000967) | 2.87722787 |
| 24 | Stomatitis (HP:0010280) | 2.86156636 |
| 25 | Recurrent viral infections (HP:0004429) | 2.81900695 |
| 26 | Gingival bleeding (HP:0000225) | 2.78960459 |
| 27 | Abnormality of macrophages (HP:0004311) | 2.78427762 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.77022190 |
| 29 | Recurrent skin infections (HP:0001581) | 2.76843813 |
| 30 | Systemic lupus erythematosus (HP:0002725) | 2.74407504 |
| 31 | Renal cortical cysts (HP:0000803) | 2.73704687 |
| 32 | Epistaxis (HP:0000421) | 2.69460535 |
| 33 | Disinhibition (HP:0000734) | 2.68148674 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.64753559 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.64753559 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.63719154 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.63719154 |
| 38 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.63719154 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.63475448 |
| 40 | IgM deficiency (HP:0002850) | 2.61887431 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.60196597 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.58322350 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 2.57055900 |
| 44 | Increased serum ferritin (HP:0003281) | 2.54815389 |
| 45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51552504 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.51552504 |
| 47 | Increased IgM level (HP:0003496) | 2.51053441 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.50677142 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.49992840 |
| 50 | Amyloidosis (HP:0011034) | 2.47865564 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.46931329 |
| 52 | Vasculitis (HP:0002633) | 2.44624441 |
| 53 | Pustule (HP:0200039) | 2.44354971 |
| 54 | Axonal loss (HP:0003447) | 2.41754978 |
| 55 | Meningitis (HP:0001287) | 2.41236539 |
| 56 | Cheilitis (HP:0100825) | 2.40099014 |
| 57 | Cellulitis (HP:0100658) | 2.39849271 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.39527547 |
| 59 | Albinism (HP:0001022) | 2.39500235 |
| 60 | Hepatosplenomegaly (HP:0001433) | 2.38002088 |
| 61 | Chronic diarrhea (HP:0002028) | 2.37452700 |
| 62 | Encephalitis (HP:0002383) | 2.36793539 |
| 63 | Abnormality of T cell physiology (HP:0011840) | 2.35523498 |
| 64 | Gingivitis (HP:0000230) | 2.33823997 |
| 65 | Glomerulonephritis (HP:0000099) | 2.32976718 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 2.32702888 |
| 67 | Neurofibrillary tangles (HP:0002185) | 2.28207519 |
| 68 | Autoimmune thrombocytopenia (HP:0001973) | 2.26602734 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.26598404 |
| 70 | Urticaria (HP:0001025) | 2.26231653 |
| 71 | Arterial thrombosis (HP:0004420) | 2.26092369 |
| 72 | Chest pain (HP:0100749) | 2.25249306 |
| 73 | T lymphocytopenia (HP:0005403) | 2.25162486 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.24115338 |
| 75 | Patchy hypopigmentation of hair (HP:0011365) | 2.23781813 |
| 76 | Agammaglobulinemia (HP:0004432) | 2.20410059 |
| 77 | Granulocytopenia (HP:0001913) | 2.17841204 |
| 78 | Leukocytosis (HP:0001974) | 2.15109962 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.14654659 |
| 80 | Menorrhagia (HP:0000132) | 2.14561041 |
| 81 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.14249969 |
| 82 | Prolonged partial thromboplastin time (HP:0003645) | 2.13860375 |
| 83 | Abnormal platelet function (HP:0011869) | 2.13822468 |
| 84 | Impaired platelet aggregation (HP:0003540) | 2.13822468 |
| 85 | Prostate neoplasm (HP:0100787) | 2.12964059 |
| 86 | Pulmonary infiltrates (HP:0002113) | 2.12743661 |
| 87 | Hematochezia (HP:0002573) | 2.12318970 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.11430660 |
| 89 | Hypergammaglobulinemia (HP:0010702) | 2.11205339 |
| 90 | Thrombocytosis (HP:0001894) | 2.10199049 |
| 91 | Abnormality of T cell number (HP:0011839) | 2.09608885 |
| 92 | Premature loss of primary teeth (HP:0006323) | 2.08902899 |
| 93 | Nuclear cataract (HP:0100018) | 2.08229152 |
| 94 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.08136253 |
| 95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06905003 |
| 96 | Abnormality of the prostate (HP:0008775) | 2.06526323 |
| 97 | Polycythemia (HP:0001901) | 2.06393007 |
| 98 | White forelock (HP:0002211) | 2.04950258 |
| 99 | Abnormal platelet volume (HP:0011876) | 2.04295497 |
| 100 | Abnormality of the nasal mucosa (HP:0000433) | 2.04279465 |
| 101 | Eosinophilia (HP:0001880) | 2.04254980 |
| 102 | Gangrene (HP:0100758) | 2.04178087 |
| 103 | Pulmonary embolism (HP:0002204) | 2.03946367 |
| 104 | Colitis (HP:0002583) | 2.03756741 |
| 105 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.03399831 |
| 106 | Polyneuropathy (HP:0001271) | 2.03346813 |
| 107 | Abnormal protein glycosylation (HP:0012346) | 2.00755548 |
| 108 | Abnormal glycosylation (HP:0012345) | 2.00755548 |
| 109 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.00755548 |
| 110 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.00755548 |
| 111 | Cerebral inclusion bodies (HP:0100314) | 1.99491875 |
| 112 | Mutism (HP:0002300) | 1.98327270 |
| 113 | Autoimmune hemolytic anemia (HP:0001890) | 1.95354330 |
| 114 | Hemoptysis (HP:0002105) | 1.94701131 |
| 115 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93308157 |
| 116 | Basal ganglia calcification (HP:0002135) | 1.92872021 |
| 117 | Osteomyelitis (HP:0002754) | 1.92719587 |
| 118 | Abnormality of T cells (HP:0002843) | 1.92126074 |
| 119 | Malnutrition (HP:0004395) | 1.91608444 |
| 120 | Vertigo (HP:0002321) | 1.90837846 |
| 121 | Episodic fever (HP:0001954) | 1.90689573 |
| 122 | Glomerulopathy (HP:0100820) | 1.88504773 |
| 123 | Clubbing of toes (HP:0100760) | 1.88313446 |
| 124 | Arthralgia (HP:0002829) | 1.87181124 |
| 125 | Abnormality of complement system (HP:0005339) | 1.86999232 |
| 126 | Chromsome breakage (HP:0040012) | 1.86113352 |
| 127 | Keratitis (HP:0000491) | 1.86090425 |
| 128 | Abnormality of the pleura (HP:0002103) | 1.85095485 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.85091658 |
| 130 | Myocardial infarction (HP:0001658) | 1.83864236 |
| 131 | Abnormality of eosinophils (HP:0001879) | 1.83524042 |
| 132 | Recurrent pneumonia (HP:0006532) | 1.82294732 |
| 133 | Obstructive lung disease (HP:0006536) | 1.81747323 |
| 134 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81747323 |
| 135 | Hypoplasia of the thymus (HP:0000778) | 1.80322406 |
| 136 | Complement deficiency (HP:0004431) | 1.78250993 |
| 137 | Alveolar cell carcinoma (HP:0006519) | 1.78238157 |
| 138 | Increased IgE level (HP:0003212) | 1.76519607 |
| 139 | Joint swelling (HP:0001386) | 1.76468211 |
| 140 | Osteomalacia (HP:0002749) | 1.74380171 |
| 141 | Anorexia (HP:0002039) | 1.72996829 |
| 142 | Bruising susceptibility (HP:0000978) | 1.71533618 |
| 143 | Generalized aminoaciduria (HP:0002909) | 1.70649375 |
| 144 | Lymphopenia (HP:0001888) | 1.70289326 |
| 145 | Hypoplasia of the fovea (HP:0007750) | 1.69109828 |
| 146 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.69109828 |
| 147 | Recurrent lower respiratory tract infections (HP:0002783) | 1.68798761 |
| 148 | Hypothermia (HP:0002045) | 1.68026987 |
| 149 | Syringomyelia (HP:0003396) | 1.68009891 |
| 150 | Spinal cord lesions (HP:0100561) | 1.68009891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.12451578 |
| 2 | MAP3K14 | 3.06270495 |
| 3 | TXK | 2.94665828 |
| 4 | IRAK4 | 2.72252657 |
| 5 | JAK3 | 2.68397477 |
| 6 | PRPF4B | 2.62766990 |
| 7 | MAP4K1 | 2.41639306 |
| 8 | TGFBR2 | 2.24453871 |
| 9 | ZAK | 2.19268779 |
| 10 | KIT | 2.17190287 |
| 11 | IKBKE | 2.15778253 |
| 12 | TEC | 2.12244224 |
| 13 | TYK2 | 2.08621852 |
| 14 | MAP2K3 | 2.00052769 |
| 15 | TAOK1 | 1.99770591 |
| 16 | ZAP70 | 1.97635650 |
| 17 | TBK1 | 1.92615573 |
| 18 | RIPK1 | 1.86511364 |
| 19 | BTK | 1.80306477 |
| 20 | INSRR | 1.79890622 |
| 21 | SIK3 | 1.77831853 |
| 22 | TAOK3 | 1.77569192 |
| 23 | IKBKB | 1.71928889 |
| 24 | TNIK | 1.70861273 |
| 25 | NLK | 1.70176566 |
| 26 | MAP3K11 | 1.66738968 |
| 27 | FGR | 1.64067180 |
| 28 | MAP3K13 | 1.63955251 |
| 29 | BLK | 1.61681638 |
| 30 | NUAK1 | 1.61220854 |
| 31 | DDR2 | 1.54929864 |
| 32 | ERN1 | 1.48440064 |
| 33 | CHUK | 1.40822194 |
| 34 | CDC42BPA | 1.36093572 |
| 35 | MAPK15 | 1.35616625 |
| 36 | FES | 1.33984816 |
| 37 | EIF2AK2 | 1.33961483 |
| 38 | FLT3 | 1.33697297 |
| 39 | MAP3K1 | 1.30533598 |
| 40 | JAK1 | 1.29696675 |
| 41 | ADRBK2 | 1.23491439 |
| 42 | YES1 | 1.15655557 |
| 43 | IRAK1 | 1.13649404 |
| 44 | TRIB3 | 1.11174312 |
| 45 | TAOK2 | 1.09372321 |
| 46 | ITK | 1.08297115 |
| 47 | TIE1 | 1.07608543 |
| 48 | LCK | 1.06131420 |
| 49 | MOS | 1.04815211 |
| 50 | LYN | 1.03211862 |
| 51 | STK10 | 1.02760131 |
| 52 | TTN | 1.01781683 |
| 53 | CSF1R | 1.01550823 |
| 54 | CLK1 | 1.01429950 |
| 55 | MARK3 | 0.99576980 |
| 56 | CSK | 0.99003935 |
| 57 | SYK | 0.98256642 |
| 58 | FGFR4 | 0.97670386 |
| 59 | EPHA3 | 0.95830026 |
| 60 | BMX | 0.95734588 |
| 61 | TNK2 | 0.95102605 |
| 62 | HCK | 0.95041917 |
| 63 | PIM1 | 0.93934984 |
| 64 | GRK6 | 0.89024997 |
| 65 | CDK3 | 0.88722698 |
| 66 | PIM2 | 0.86082576 |
| 67 | TRPM7 | 0.85701918 |
| 68 | SIK1 | 0.84986964 |
| 69 | MAP2K6 | 0.81472028 |
| 70 | MAPK7 | 0.78815738 |
| 71 | KSR2 | 0.78583327 |
| 72 | NME2 | 0.77823223 |
| 73 | TESK2 | 0.77604399 |
| 74 | NEK9 | 0.77242543 |
| 75 | BMPR1B | 0.76737222 |
| 76 | KDR | 0.76449433 |
| 77 | STK16 | 0.75059840 |
| 78 | PIK3CG | 0.74998867 |
| 79 | PASK | 0.74312937 |
| 80 | MARK2 | 0.71667998 |
| 81 | MATK | 0.68566467 |
| 82 | PDPK1 | 0.68464271 |
| 83 | TESK1 | 0.68350330 |
| 84 | MAP3K5 | 0.66964509 |
| 85 | TGFBR1 | 0.65891394 |
| 86 | GRK7 | 0.64985443 |
| 87 | IRAK2 | 0.64894661 |
| 88 | PDK1 | 0.64234912 |
| 89 | PRKAA2 | 0.63832753 |
| 90 | RIPK4 | 0.62415821 |
| 91 | CAMK1D | 0.61744712 |
| 92 | RPS6KA4 | 0.61020548 |
| 93 | FGFR3 | 0.59319310 |
| 94 | BMPR2 | 0.57402929 |
| 95 | PRKG2 | 0.56746053 |
| 96 | CDK12 | 0.56445800 |
| 97 | PDGFRA | 0.56303608 |
| 98 | PTK2B | 0.54171754 |
| 99 | GRK1 | 0.53883568 |
| 100 | VRK1 | 0.53774643 |
| 101 | JAK2 | 0.52903019 |
| 102 | ARAF | 0.52490597 |
| 103 | EPHA2 | 0.52244309 |
| 104 | ABL2 | 0.51463581 |
| 105 | CAMKK2 | 0.51020808 |
| 106 | STK24 | 0.50737407 |
| 107 | MAP3K3 | 0.49404033 |
| 108 | EPHB1 | 0.49220269 |
| 109 | MAPK12 | 0.48531594 |
| 110 | ERBB3 | 0.48114004 |
| 111 | MAPK4 | 0.47420203 |
| 112 | IGF1R | 0.47263687 |
| 113 | HIPK2 | 0.47027437 |
| 114 | MKNK2 | 0.46760548 |
| 115 | MAPK11 | 0.46335323 |
| 116 | BCKDK | 0.45951886 |
| 117 | SIK2 | 0.45950739 |
| 118 | ABL1 | 0.45737651 |
| 119 | NEK6 | 0.45307105 |
| 120 | EIF2AK3 | 0.45092296 |
| 121 | SGK2 | 0.44497057 |
| 122 | SMG1 | 0.43766417 |
| 123 | PRKD2 | 0.43503115 |
| 124 | MAPK3 | 0.41979595 |
| 125 | MAP3K6 | 0.41407530 |
| 126 | PRKCD | 0.41225314 |
| 127 | PDGFRB | 0.40528173 |
| 128 | STK3 | 0.40481900 |
| 129 | ICK | 0.40358817 |
| 130 | RPS6KC1 | 0.39814785 |
| 131 | RPS6KL1 | 0.39814785 |
| 132 | FYN | 0.39810921 |
| 133 | MAPKAPK2 | 0.38236128 |
| 134 | MKNK1 | 0.37464190 |
| 135 | PTK6 | 0.37388162 |
| 136 | SGK3 | 0.34567417 |
| 137 | PRKD1 | 0.33153565 |
| 138 | ACVR1B | 0.31973625 |
| 139 | RPS6KA2 | 0.30910828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.77011027 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54925989 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33201053 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31482949 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20600543 |
| 6 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.19042303 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.14514193 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.12547827 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.07258930 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84538367 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81802967 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.81124911 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.79331753 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.78515968 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.75304588 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.71680059 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.60622961 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58180763 |
| 19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.56527401 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.56403830 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52614390 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.52020249 |
| 23 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51905198 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.51767803 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.50161760 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49187539 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.48089024 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.45171235 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45130774 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43121973 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42931629 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.41518523 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39516852 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.38957615 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34417960 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28258527 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26991636 |
| 38 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20200017 |
| 39 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14322277 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13611627 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.13602943 |
| 42 | Protein export_Homo sapiens_hsa03060 | 1.11932376 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09631701 |
| 44 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.08816283 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.04953108 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.04662651 |
| 47 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04310382 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.03498525 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00080817 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.98469736 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.98446920 |
| 52 | Amoebiasis_Homo sapiens_hsa05146 | 0.97546059 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.97541108 |
| 54 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.97217017 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95626396 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.94730472 |
| 57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.93375654 |
| 58 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92868356 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.92679345 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91868886 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91696451 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.91322745 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.90369948 |
| 64 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90021718 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89229771 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.89096002 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87440927 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85803085 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84931108 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82879544 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81578683 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80739433 |
| 73 | Hepatitis B_Homo sapiens_hsa05161 | 0.80522132 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80496125 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80031240 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78788377 |
| 77 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77612302 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.77391757 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77058913 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75697030 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.75445678 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.75307922 |
| 83 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74122842 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73481508 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73277810 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.71224169 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70446744 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.70287245 |
| 89 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69648842 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68246888 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68087427 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66776360 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65992632 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.65132010 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64978239 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63878654 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63801995 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60790501 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60764089 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60139299 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58024216 |
| 102 | Base excision repair_Homo sapiens_hsa03410 | 0.57712971 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.57491191 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57333898 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.56619145 |
| 106 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56167033 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55091327 |
| 108 | Platelet activation_Homo sapiens_hsa04611 | 0.53427964 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52989182 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52389040 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51678522 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51032574 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50746603 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.50563446 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48466785 |
| 116 | Homologous recombination_Homo sapiens_hsa03440 | 0.46445401 |
| 117 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45660488 |
| 118 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.45546329 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45224433 |
| 120 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43716982 |
| 121 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43342263 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43269503 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43173114 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40866920 |
| 125 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40125944 |
| 126 | Salmonella infection_Homo sapiens_hsa05132 | 0.37470418 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35956941 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35944072 |
| 129 | Phagosome_Homo sapiens_hsa04145 | 0.35797297 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35541254 |
| 131 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35285524 |
| 132 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35226746 |
| 133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34453613 |
| 134 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34389876 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33695412 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28893231 |

